Government Initiatives in Autism Clinical Trials

Benedetto Vitiello, Ann Wagner

Research output: Contribution to journalReview articlepeer-review

Abstract

Randomized clinical trials remain the most valid method of testing the efficacy and safety of treatments. While efforts to elucidate the genetic and neurodevelopmental bases of autism are underway, clinicians and families are in need of scientifically valid information on how to best treat patients with autism. The effectiveness of many interventions currently used in communities has not been adequately tested. Given the high public health relevance of autism treatment research and the low interest of the pharmaceutical industry in autism, the role of the National Institutes of Health in supporting this research is paramount. Among recently launched initiatives in autism clinical trials, there are the Research Units on Pediatric Psychopharmacology Autism Network and the network of centers for Studies to Advance Autism Research and Treatment. These and other government activities in the area of autism clinical trials are here briefly reviewed.

Original languageEnglish (US)
Pages (from-to)66-70
Number of pages5
JournalCNS spectrums
Volume9
Issue number1
DOIs
StatePublished - Jan 2004

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Government Initiatives in Autism Clinical Trials'. Together they form a unique fingerprint.

Cite this